Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor (NCT05933395)
Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to learn if certain drug combinations are effective treatments for patients with advanced ER+/HER2- who have previously been treated with palbociclib, ribociclib, or abemaciclib.
Who can join: Review the eligibility criteria below.
Location: Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
📞 Contact the Study Coordinator
Phone: (603) 650-5021
Email: hem-onc.research.nurses@hitchcock.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Advanced Breast Cancer
- RCT of CBD for Anxiety in Advanced Breast Cancer — Boston, Massachusetts
- A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Encinitas, California
- A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer — Springdale, Arkansas
- Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer — St Louis, Missouri
- Engage Psychosocial Intervention for Cancer Symptoms — Durham, North Carolina
- A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors — Duarte, California
Explore by condition: All Advanced Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.